DNA probes and genetic screening
Studying this course? Keep your progress in one place.
Key facts
- The base sequence of DNA differs between individuals because of different alleles, mutated alleles and differences in non-coding DNA.
- A DNA probe is a short, single-stranded piece of DNA, complementary to a target sequence and carrying a label.
- DNA hybridisation is the probe binding to its complementary sequence by hydrogen bonds.
- Screening finds heritable conditions, drug responses and health risks. A positive result is not certainty.
- Genetic counselling explains risk; personalised medicine matches drugs to a person’s genotype.
Differences in DNA
Individuals of one species have almost identical DNA, but the base sequence differs in places, and these differences can be detected.
The differences include different alleles of a gene, mutated alleles, and differences in non-coding DNA.
They can be used to identify individuals and to diagnose a heritable condition such as cystic fibrosis, Huntington’s disease or some cancers.
- 1
Compare DNA sequences
Members of one species have almost identical DNA
- 2
Find differences
Different alleles, mutated alleles, non-coding DNA
- 3
Use the differences
Identify individuals; diagnose heritable conditions
- Same speciesalmost identical DNA
- Different base sequenceidentify people, diagnose conditions
Why can DNA differences be used to diagnose a heritable condition?
DNA probes
A DNA probe is a short, single-stranded piece of DNA with a base sequence complementary to part of a target allele, and a label so it can be found.
A DNA probe binds to the allele whose sequence it matches. Probes can be made for any allele whose sequence is known, including mutated alleles that cause disease.
The label makes the bound probe detectable.
- 1
Separate the DNA into single strands
The sample is denatured
- 2
Add a labelled probe
Radioactive or fluorescent label
- 3
Probe binds to the matching allele
Complementary base sequence
- 4
Detect the label
X-ray film darkens, or fluorescence is seen
Radioactive label
- Detected by darkening of X-ray film
Fluorescent label
- Detected by the fluorescence it gives out
Which two features let a DNA probe find a target allele?
DNA hybridisation
The DNA is made single-stranded, mixed with the labelled probe, washed, and then checked for a signal from bound probe.
DNA hybridisation is the binding of the probe to its complementary sequence by hydrogen bonds. It only happens if the target allele is present.
If the sample is small, the DNA can first be copied by PCR and cut into fragments.
- 1
Extract
DNA from the patient’s cells, such as blood or cheek cells
- 2
Heat
to break hydrogen bonds and give single-stranded DNA
- 3
Add labelled probe
it binds to the target allele if present
- 4
Wash
to remove unbound probe
- 5
Detect
the label; a signal means the allele is present
Why is unbound probe washed off before detection?
Uses of screening
Labelled probes screen patients for heritable conditions, for drug responses and for alleles that raise the risk of disease.
Screening tests for a particular allele. A positive result shows that the allele is present. It does not always mean the person will develop the condition.
A carrier has one copy of a recessive allele without having the condition.
- 1
Sample taken
From an adult, embryo or fetus
- 2
Test for a specific allele
e.g. cystic fibrosis allele, BRCA1
- 3
Result
Positive means the allele is present, not that the condition is certain
Heritable conditions
- Finds disease-causing alleles
- Tests carriers, embryos or a fetus
Drug response
- Alleles that change how a drug is absorbed, activated or broken down
Health risks
- Alleles that raise the risk of disease
- For example BRCA1 and BRCA2
A woman has a positive screening result for a BRCA1 allele. What can be concluded?
Counselling and personalised medicine
Genetic counselling explains what a result means, and personalised medicine uses a genotype to pick the best drug and dose.
Genetic counselling explains results and works out the probability of passing on an allele. It describes the options and helps people make their own informed decisions.
Personalised medicine uses a patient’s genotype to choose the drug and dose most likely to work, so treatment is more effective with fewer side effects.
- Two carriers, Ff × Ff1/4 affected, 1/2 carriers
Worked example
Two carriers (Ff × Ff) have two children. What is the probability that one child is affected, and that both are?
- 1
Ff × Ff gives FF, Ff, Ff and ff in the ratio 1 : 2 : 1.
- 2
Only ff is affected, so the probability for one child is 1/4 = 0.25.
- 3
Births are independent, so multiply: 0.25 × 0.25.
What is the probability that a child of two carriers is also a carrier?
Evaluating screening
Screening brings earlier treatment and informed choices, but also anxiety, uncertainty and privacy concerns.
When given data, quote and compare the figures, such as the risk with and without the allele and the proportion of people who carry it. End with a justified conclusion.
A negative result may give false reassurance because the test only looks for specific alleles.
- 1
Quote the figures
Risk with and without the allele; proportion who carry it
- 2
Weigh benefits and drawbacks
Earlier treatment against anxiety, cost and privacy
- 3
Justified conclusion
Say which outweighs the other and why
Benefits
- Earlier diagnosis and treatment
- Preventive action
- Informed family planning
- Better drug choice
Drawbacks
- Anxiety
- A positive result is not certainty
- Cost if few people carry the allele
- Privacy, insurance and employment concerns
- Difficult decisions about pregnancy
Give one reason why a negative screening result may give false reassurance.
Try an exam question
Describe how a labelled DNA probe is used to find a mutated allele in a sample of DNA.
[4 marks]
- [1]DNA is extracted and heated to separate it into single strands.
- [1]A labelled probe, with a base sequence complementary to the mutated allele, is added.
- [1]The probe binds to the allele by hydrogen bonds if it is present (hybridisation), and unbound probe is washed off.
- [1]The label (radioactive or fluorescent) is detected; a signal shows the allele is present.
That's the notes covered.
Carry on to the next subtopic.
Try a question
Why can the probe be used to locate the allele in the patient's DNA?
1 mark, marked against the mark scheme
Why can the probe be used to locate the allele in the patient's DNA?
1 mark, marked against the mark scheme